The Controversy of Tobacco Control Policies in India

Nov.25.2022
The Controversy of Tobacco Control Policies in India
The use of psychoactive substances is controlled in India due to health and moral concerns, but policies and attitudes lack input from addiction experts.

Due to various health and ethical reasons, the use of psychoactive substances is subject to regulation by society or government. In general, Indian society tends to discourage the use of psychoactive substances for pleasure. Although humans have been using psychoactive substances to alter their mental states since ancient times, they are only allowed to use substances approved by the state or society. This is reflected in the policies and attitudes towards various psychoactive substances.


In 2019, India banned all types of e-cigarettes based on the recommendation of the ICMR committee. The committee consisted of renowned doctors and scientists from various disciplines, but lacked the presence of behavioral scientists and addiction experts. This implies that those with knowledge of tobacco or ENDS addiction were not part of the committee that proposed the ban.


In most studies on tobacco use disorders, it is common to find a lack of participation from psychiatrists and behavioral scientists.


This situation occurs because authorities often do not acknowledge tobacco as a part of the class of psychoactive substances. In the case of other psychoactive substances, such as alcohol or drugs, they are clearly considered addictive substances, but this is not the case with tobacco. Whenever tobacco policy is discussed, the perspectives of addiction experts and behavioral scientists are not given the attention they deserve.


Strategies for managing psychoactive substances can be broadly categorized into supply control (strategies that involve controlling the availability of the substance), demand reduction (strategies that aim to reduce the need for the substance), and harm reduction (strategies that aim to minimize the negative consequences of substance use). Of these, harm reduction is considered the most pragmatic approach since reducing 80% of the harm caused by substance use is better than reducing none of it at all.


The supply-control strategy is the most popular strategy, despite its lack of effectiveness. Most law-abiding individuals believe that "prohibition" means unavailable. Unfortunately, this is not the case. Prohibition actually means that the government is not regulating the substance. The consequences of prohibition are foreseeable - criminals and organized crime control the supply of this substance.


If I buy a bottle of whiskey in Delhi, I can reasonably assume that I am purchasing whiskey. However, this is not the case in the prohibition states of Bihar and Gujarat, where the sale of alcohol is banned.


If someone buys an electronic cigarette in Delhi, they cannot be sure of what substance they are actually getting. The e-liquid used in electronic cigarettes contains high levels of nicotine and various other chemicals. If the government were to regulate them, they could closely monitor the quality of the products people are consuming. Despite the ban, are electronic cigarettes really unavailable in Delhi? Can anyone be held accountable for the ingredients in the e-liquid?


Do people in India use electronic cigarettes? Yes, there are millions of people who do. But if the ban is strictly enforced, they will revert back to smoking traditional cigarettes and other tobacco products.


Any discussion about whether electronic cigarettes should be regulated as harm reduction products should take into account the authorities' actions in relation to combustible tobacco products. When doctors are compelled to sit down and discuss research on harm reduction products, no one pays attention to what happens to people who have been using combustible cigarettes for years.


If we account for inflation, the price of combustible tobacco has remained constant over the past two years. While almost all basic commodities have increased in price, combustible tobacco has remained unchanged.


There are various methods to reduce the risks and harms associated with the use of any substance. Products being used can be altered or simply the environment of consumption can be changed to decrease associated stigma and discrimination. Therefore, various methods can be applied to the use of psychoactive substances including tobacco. One possible method may be encouraging the use of lower risk products.


Drug addiction is a persistent problem, and it is necessary to provide alternatives for those afflicted. In our daily lives, we are familiar with examples of harm reduction, such as using condoms, wearing helmets while riding a bike, and wearing seatbelts while driving. Not drinking and driving is also a widely accepted, promoted, and encouraged behavior. However, when it comes to tobacco, such measures are lacking.


Sweet words of a drug-free or tobacco-free world will not get us anywhere, as people will find ways to obtain nicotine. Whether we like it or not, this is a human demand. Some people simply cannot quit smoking, and we need to have empathy for them. Some rely on tea or coffee to stay alert and energized, and we should stop judging them.


We need to empathize with those who believe they cannot work without nicotine and require it in some form. Both policy makers and medical professionals seem to lack this empathy. It is true that the currently available products for nicotine delivery may not be entirely satisfactory. The products on the market may have some issues, but with a ban, we will be shutting down all potential research and development.


If products that reduce harm are considered possible alternatives, research can still be conducted to achieve improvement. Nicotine can be further regulated and harmful substances such as nitrosamines can be reduced in such products to make them less harmful and relatively safer.


While individuals are sympathetic towards those suffering from cancer or heart diseases, those addicted to tobacco receive no support. This causes them distress and they require help, compassion, and sympathy.


The Indian government has officially recognized harm reduction as a method for dealing with mental drugs. Other countries and regions have also been promoting and encouraging various types of harm reduction methods.


For example, some countries allow "drug consumption rooms" where individuals can use their own drugs within facilities that provide nursing assistance. This ensures that if problems arise, their lives can at least be saved. One might wonder if this is encouraging drug use. However, the focus here is on saving lives rather than making moral judgments about an individual's actions.


Our laws do indeed prohibit certain products that are harmful to health. This is not a moral stance against the use of psychoactive substances, but simply emphasizes the health outcomes. Therefore, policies such as bans unintentionally increase the harm caused by psychoactive substances. The ban on opium products seems to have led to the heroin epidemic in the country. We are currently banning electronic cigarettes, while more harmful combustible cigarettes continue to be widely available. This mistake has inadvertently maximized harm.


Unfortunately, there is still strong resistance to reducing the harm caused by tobacco. In the midst of moral, scientific, and commercial disagreements, we need to sit down and find solutions. Doctors need to work in multiple ways to gather evidence and avoid accusations of conflicts of interest.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the viewpoints of 2FIRSTS and the company cannot confirm the authenticity and accuracy of the article's content. The translation of this article is only intended for industry exchange and research purposes.


Due to limitations in translation ability, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong-Macau-Taiwan related, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's parliament is scheduled to hold a first reading of amendments to the Tobacco Tax Act on September 24. The government plans annual tax increases from 2027 through 2030 covering cigarettes, heated tobacco, vaping liquids and other categories. It expects the reform to generate €756 million in additional revenue in 2027, rising to €3.589 billion in additional annual revenue by 2030. Ahead of the parliamentary debate, the German Association of the Tobacco Industry and Novel Products, or BVTE, launched the "Tabaksteuer mit Augenmaß" campaign backed by BAT, JTI, Philip Morris, Reemtsma and wholesale and retail groups.
Sep.23
Major U.S.  Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
Major U.S. Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
New York vape distributor Ecto World, which operates as Demand Vape, hired political consultant Roger Stone to lobby the Executive Office of the President on regulation of vaping and related products while facing state enforcement and multiple lawsuits. Public lobbying disclosures show that Ecto World paid at least $300,000 for the work through June 30, 2026. Separately, New York State announced in March that more than 28,500 pounds of vaping products tied to the company had been seized, while New York City and the state have pursued legal or enforcement actions. Public records do not show that the lobbying directly changed any specific regulatory or enforcement outcome.
Sep.08
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
Special Report|AIR H1 Revenue Rises 3.7% as Shisha Volumes Fall 9%, Testing Its Shift Beyond Traditional Hookah
AIR’s first half-year results as a listed company offer a new test of how far a traditional hookah business can transform. H1 2026 revenue rose 3.7%, even as Flavored Shisha Molasses shipments fell 9%, with pricing and mix supporting growth. Traditional shisha still generates almost all revenue, while OOKA, Crown Switch, Greentank and U.S. regulatory spending point to accelerating diversification. The next test is whether those investments can become a second business of meaningful scale and profitability.
Capital Markets
Aug.21
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24